Champions Oncology (CSBR) Tops Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.07 -0.2%
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q1 EPS of $0.02, $0.03 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $14 million versus the consensus estimate of $14.7 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
- SanDisk upgraded at JPMorgan after investor day; shares climb
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
